BioSpace News Archive

CooperCompanies announced that the company, along with its CooperVision and CooperSurgical divisions has been named one of Fortune’s Best Large Workplaces in Manufacturing and Production.

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Zynerba’s Chief Executive Officer, Armando Anido will participate in two upcoming virtual investor conferences. Mr. Anido will present a company overview at the HC Wainwright Virtual 22 nd Annual Healthcare Conference on Monday September 14, 2020 a

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that members of management will present virtually at the H.C. Wainwright & Co. 22 nd Annual Global Investment Confe

Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update about the Company’s progress at the Morgan Stanley 18 th Annual Global Healthcare Conference. The presentation will take place on Tuesday, Septemb

Patients using Science 37’s technology platform can now connect their health record directly, in real time--eliminating paper documentation and streamlining information sharing [10-September-2020] LOS ANGELES , Sept.10, 2020 /PRNewswire/ -- Science 37, the industry leader in decentralized clinical trials, today launched an electronic health record (EHR) integration feat

Zogenix (Nasdaq: ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today reported positive top-line results from its third Phase 3 study (Study 3) of FINTEPLA® (fenfluramine) oral solution for the treatment of seizures associated with Dravet syndrome.

Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company, today announced that it will present data from its ongoing Phase II studies of GA Depot for the treatment of relapsing remitting multiple sclerosis (RRMS) and primary progressive multiple sclerosis (PPMS) at MS Virtual 2020,

Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, today announced topline results from its Phase 3 EMERGE efficacy trial of STS101 (dihydroergotamine (DHE) nasal) powder as an acute treatment for migraine.

Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LTB4) systems are implicated, today announced that Clive Richardson, Chief Executive Officer, will participate and host investor meetings during the following upcoming virtual investor conferences: Event: H.C. Wainwright 22 n

Centene Corporation (NYSE: CNC) announced today it will participate at the Morgan Stanley Virtual 18 th Annual Global Healthcare Conference, to be held September 14-September 18, 2020 . Centene will participate in a virtual format on Monday, September 14, 2020 , at 10:30 a.m. Eastern Daylight Time (EDT). A simultaneous l